Amphipol Polymer Complexes for Transdermal Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for transdermal delivery of charged and higher molecular weight bioactive agents face significant barriers due to the stratum corneum's lipid bilayer and tight junctions in the skin, often resulting in skin irritation and limited effectiveness, particularly for hydrophilic and charged molecules like proteins and polynucleotides.
Innovation Solution
The use of amphipol polymers for hydrophobic ion pairing with charged bioactive agents to enhance their lipophilicity, allowing them to diffuse through the skin's lipid bilayer without causing damage, combined with TJ-modulating peptides to facilitate passage through tight junctions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional penetration enhancers (solvents, detergents) are used to permeabilize the stratum corneum, then transdermal delivery of small lipophilic molecules is improved, but skin irritation and sensitization increase
Solution Approach 1:
The patent introduces amphipol polymers as intermediary carriers that bind to charged bioactive agents through hydrophobic ion pairing, forming complexes that can penetrate the stratum corneum without requiring harsh chemical enhancers. The amphipol polymer acts as a mediator between the charged molecule and the lipid bilayer, enabling transport while maintaining skin integrity.
Solution Approach 2:
The invention changes the physical-chemical parameters of the bioactive agent by forming ion-paired complexes with amphipol polymers, which alter the molecule's lipophilicity and molecular size. This parameter change enables charged molecules to penetrate the lipophilic stratum corneum barrier without damaging it, as the complex format allows passage through both the lipid bilayer and tight junctions.
2Reliability
If charged polypeptides and polynucleotides are delivered transdermally, then therapeutic effect is improved, but the lipid bilayer and tight junctions block their passage
Solution Approach 1:
The amphipol polymer serves as a molecular chaperone and intermediary carrier that facilitates the transport of charged polypeptides and polynucleotides through the skin barrier. The polymer binds to the charged bioactive agent via hydrophobic ion pairing, creating a complex that can navigate through both the lipid bilayer of the stratum corneum and the tight junctions of the stratum granulosum.
Solution Approach 2:
The invention creates composite structures by forming non-covalent ion-paired complexes between amphipol polymers and charged bioactive agents. These composite complexes have enhanced lipophilicity and appropriate molecular dimensions that enable them to penetrate the skin barrier, combining the properties of both the polymer carrier and the bioactive molecule.
3Adaptability or versatility
If ionic detergents are used for hydrophobic ion pairing of charged proteins, then protein solubility in organic solvents is improved, but skin tissue degradation and inflammatory reactions occur
Solution Approach 1:
The patent employs amphipol polymers as temporary, non-damaging carriers that perform their function of solubilizing charged proteins through hydrophobic ion pairing and then dissipate or are metabolized without causing harm. Unlike persistent ionic detergents that remain in the skin and cause degradation, the amphipol polymers provide transient assistance during penetration and do not accumulate to harmful levels.
Solution Approach 2:
The invention converts the potentially harmful property of ionic detergents (which can denature proteins and damage skin) into a beneficial temporary solubilizing effect. The amphipol polymers provide the necessary hydrophobic interaction to solubilize charged proteins in the skin environment without the damaging side effects of conventional ionic detergents, as they lack the strong ionic character that causes tissue degradation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables safer and more effective dermal and transdermal delivery of a wide range of bioactive agents, including proteins and polynucleotides, by enhancing their lipophilicity and facilitating their passage through the skin's barriers, improving skin appearance and treating various skin disorders.
Implementation Method 1
The use of amphipol polymers for hydrophobic ion pairing with charged bioactive agents to enhance their lipophilicity
Implementation Method 2
enhancing their lipophilicity, allowing them to diffuse through the skin's lipid bilayer
Implementation Method 3
allowing them to diffuse through the skin's lipid bilayer
Implementation Method 4
combined with TJ-modulating peptides to facilitate passage through tight junctions
Data Source
AI summary
The invention provides topical formulations and methods comprising charged bioactive agents complexed with amphipol polymers for dermal and transdermal delivery, optionally further including TJ-modulating peptides.